Executive Team

Michael Feldschuh,  President and Chief Executive 

Michael has held the position of president and CEO of Daxor Corporation since 2017. Prior to this, he served as a member of the board of directors before joining Daxor’s executive team in December of 2014. Michael has over 25 years of experience on Wall Street and in the medical field. He served as a managing director and portfolio manager for Morgan Stanley for six years and a managing director of Millennium Partners for eight years in addition to leading his own hedge fund, Aristarc Capital, from 2009 to 2013. Michael began his career at D.E. Shaw & Co. in New York, where he worked with Jeffery Bezos prior to Bezos’s founding of Amazon. Michael earned his bachelor’s degree in pre-med studies at Columbia College, Columbia University in 1991. Michael’s interests include photography and travel.


Robert J. Michel, Chief Financial Officer

Bob is a certified public accountant and gained his public accounting experience at Price Waterhouse in New York the predecessor firm to pwc. Bob graduated from Villanova University’s School of Business with a degree in Business Administration and has an MBA from St. John’s University. He has a diverse background with more than 30 years of financial experience in manufacturing, advertising and financial services. Immediately prior to joining Daxor Corporation, Bob was the CFO of a moving and storage company most recently at Sher-Del Transfer and Relocation Services. Bob was the CFO for 7 years at Asta Funding, Inc., a publicly traded diversified financial services company that trades on the Nasdaq. He enjoys running, cycling and has hiked across the Grand Canyon.


Jonathan Feldschuh,  Chief Scientific Officer

Jonathan is the co-inventor of the BVA-100 and associated patents. He is responsible for algorithmic design, statistical analysis and for patent applications for the next generation blood volume analyzer and its utility across diverse surgical and medical conditions. Jonathan has developed black-box trading and analytical systems for Wall Street firms such as Morgan Stanley, Millennium Partners, and Shearson Lehman and served in the past as chief quantitative officer for Aristarc Capital and as the CEO of Outseeker, a data-driven technology startup. Jonathan has an A.B. in physics summa cum laude from Harvard. He enjoys art and rock climbing.


John L Jefferies, M.D., Chief Medical Officer

John is a board certified cardiologist. He completed his training in Adult Cardiovascular Diseases at the Texas Heart Institute and Pediatric Cardiology at Texas Children’s Hospital both at the Baylor College of Medicine in Houston, Texas. He received an MPH from the University of Kentucky and an MBA from the Wharton School of Business at the University of Pennsylvania. John has published over 300 peer-reviewed manuscripts focused on heart failure, cardiomyopathies, heritable disease, genetics, and artificial intelligence, and is an Editor of two leading cardiovascular textbooks. He has been an academic cardiologist for over two decades and remains actively involved in clinical research and physician leadership roles at the local, national, and international levels. John’s interests include outdoor sports and travel.


Kathryn A. Kornafel, Sr. VP Marketing & Commercial Development

Kathy has held leadership roles in global marketing, business development, and sales with major international IVD medical device companies including Abbott, HemoCue and Ortho Clinical Diagnostics. In addition to her business experience, Kathy is an American Society of Clinical Pathology-certified Medical Technologist with clinical lab experience in hematology and microbiology. She holds a bachelor degree in biology from University of Delaware and a bachelor of science degree in medical technology from Thomas Jefferson University. Kathy’s interests include water sports and travel.


Jean Oertel, Sr. VP of Commercialization & Customer Experience

Jean has more than 25 years of MedTech experience, including 15 years of sales and marketing leadership positions in multiple divisions of Medtronic.  While at Medtronic and other industry leading companies such as Johnson and Johnson, Boston Scientific and Zoll Medical she built a track record of high-performance teams, and excellent customer service.  She has since worked in senior executive roles with MedTech startups.

Jean holds a Bachelor of Business Administration from University of Cincinnati.  She completed her executive level education in Management, Strategic Leadership and Digital Analytics at Rollins College Crummer Graduate School of Business, University of Pennsylvania, Wharton School of Business, and Massachusetts Institute of Technology.


Linda Cooper, Vice President Development & Operations

Linda has over 30 years of experience in product development and commercialization in the medical device industry. She has held senior leadership roles with major medical device companies including OsteoCentric Technologies and Integra LifeSciences where she oversaw multiple product launches through the entire product development process including hardware design, testing, regulatory clearance, and launch. She earned her Bachelor of Science degree in biomedical engineering from the University of Iowa and is an inventor on a U.S. patent for a bone plate system for repair of proximal humeral fracture. Linda’s interests include yoga and travel.


Noa Kohl, Vice President of Grants & Contracts

Noa is a trained cellular and molecular biologist with research experience at the Weizmann Institute of Science and Weill Cornell Medical School. She has over 10 years of experience in assisting life science organizations secure non-dilutive funding from U.S. federal agencies and private foundations. Noa has developed a robust portfolio of grants and contracts to support the development and validation of Daxor technologies. She holds a Bachelor and Master of Science in Cell and Molecular Biology and Genetic Engineering, as well as a Master of Business Administration from the University of Tel Aviv. Noa’s interests include technology, languages, and bioethics.

Partner With the Dedicated Leader in BVA

As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.

Volume is Vital. End the Debate With Daxor.

Call us at 865-425-0555.


Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.

Daxor Corporation – 107 Meco Lane, Oak Ridge, TN 37830
Phone: 865-425-0555 | Fax: 865-425-0551
info@daxor.com | daxor.com

ISO 13485 Certified

Made in the USA.